It is also the first to investigate the impact of ADF-LC on serum immune biomarkers relevant to obesity, autoimmunity, and cancer immunology, particularly PD-L1, offering insights into designing dietary interventions for cancer prevention, autoimmune disease management, or immune checkpoint inhibition enhancement in cancer treatment. This evidence concerns the gene CD274 and obesity disorder.